Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2025-04-04 19:12 Tx date 2025-04-01 |
$GUD
Knight Therapeutics Inc. |
Zanqueta Coelho Peev, Cristiane
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$30,467
+4,938 vol $6.17 each |
5,200 | |
Filed 2025-04-04 19:10 Tx date 2025-04-01 |
$GUD
Knight Therapeutics Inc. |
Zanqueta Coelho Peev, Cristiane
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
57 - Exercise of rights
|
$-20,282.53
-3,893 vol $5.21 each |
13,379 | |
Filed 2025-04-04 19:07 Tx date 2025-04-01 |
$GUD
Knight Therapeutics Inc. |
Zanqueta Coelho Peev, Cristiane
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
57 - Exercise of rights
|
$-20,282.53
-3,893 vol $5.21 each |
13,379 | |
Filed 2025-03-29 16:48 Tx date 2025-03-24 |
$GUD
Knight Therapeutics Inc. |
Zanqueta Coelho Peev, Cristiane
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
56 - Grant of rights
|
$25,777
+4,151 vol $6.21 each |
17,272 | |
Filed 2025-03-29 16:47 Tx date 2025-03-24 |
$GUD
Knight Therapeutics Inc. |
Zanqueta Coelho Peev, Cristiane
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
56 - Grant of rights
|
$25,777
+4,151 vol $6.21 each |
17,272 | |
Filed 2024-09-18 14:23 Tx date 2024-09-15 |
$GUD
Knight Therapeutics Inc. |
Zanqueta Coelho Peev, Cristiane
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,545
+262 vol $5.90 each |
262 | |
Filed 2024-09-18 14:22 Tx date 2022-01-24 |
$GUD
Knight Therapeutics Inc. |
Zanqueta Coelho Peev, Cristiane
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2024-04-16 18:59 Tx date 2024-04-12 |
$GUD
Knight Therapeutics Inc. |
Zanqueta Coelho Peev, Cristiane
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
56 - Grant of rights
|
$26,938
+4,726 vol $5.70 each |
13,121 | |
Filed 2024-04-16 18:58 Tx date 2024-04-12 |
$GUD
Knight Therapeutics Inc. |
Zanqueta Coelho Peev, Cristiane
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
56 - Grant of rights
|
$26,938
+4,726 vol $5.70 each |
13,121 | |
Filed 2023-04-03 22:02 Tx date 2023-03-30 |
$GUD
Knight Therapeutics Inc. |
Zanqueta Coelho Peev, Cristiane
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
56 - Grant of rights
|
$19,988
+4,502 vol $4.44 each |
8,395 | |
Filed 2023-04-03 22:00 Tx date 2023-03-30 |
$GUD
Knight Therapeutics Inc. |
Zanqueta Coelho Peev, Cristiane
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
56 - Grant of rights
|
$19,988
+4,502 vol $4.44 each |
8,395 | |
Filed 2022-09-15 09:58 Tx date 2022-03-24 |
$GUD
Knight Therapeutics Inc. |
Zanqueta Coelho Peev, Cristiane
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
56 - Grant of rights
|
$20,282
+3,893 vol $5.21 each |
3,893 | |
Filed 2022-09-15 09:57 Tx date 2022-03-24 |
$GUD
Knight Therapeutics Inc. |
Zanqueta Coelho Peev, Cristiane
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
56 - Grant of rights
|
$20,282
+3,893 vol $5.21 each |
3,893 | |
Filed 2022-03-29 11:45 Tx date 2022-03-24 |
$GUD
Knight Therapeutics Inc. |
Zanqueta Coelho Peev, Cristiane
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
56 - Grant of rights
|
$24,346
+4,673 vol $5.21 each |
||
Filed 2022-03-29 11:44 Tx date 2022-03-24 |
$GUD
Knight Therapeutics Inc. |
Zanqueta Coelho Peev, Cristiane
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
56 - Grant of rights
|
$24,346
+4,673 vol $5.21 each |
||
Filed 2022-03-29 11:45 Tx date 2022-03-24 |
$GUD
Knight Therapeutics Inc. |
Zanqueta Coelho Peev, Cristiane
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
56 - Grant of rights
|
$24,346
+4,673 vol $5.21 each |
4,673 | |
Filed 2022-03-29 11:45 Tx date 2022-01-24 |
$GUD
Knight Therapeutics Inc. |
Zanqueta Coelho Peev, Cristiane
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2022-03-29 11:44 Tx date 2022-03-24 |
$GUD
Knight Therapeutics Inc. |
Zanqueta Coelho Peev, Cristiane
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
56 - Grant of rights
|
$24,346
+4,673 vol $5.21 each |
4,673 | |
Filed 2022-03-29 11:44 Tx date 2022-01-24 |
$GUD
Knight Therapeutics Inc. |
Zanqueta Coelho Peev, Cristiane
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
00 - Opening Balance-Initial SEDI Report
|